- Abstract Number: 0045
KBD051, a Novel and Highly Selective Oral TLR7/8 Antagonist, Demonstrates Prolonged Pharmacodynamic Activity and Profound Efficacy in Preclinical Models of Systemic Lupus Erythematosus
- Abstract Number: 1092
Kidney Damage in Lupus Nephritis and Other Glomerular Diseases is Characterized by a Urinary Complement and Matrix Remodeling Signature
- Abstract Number: 1229
Kidney Function Preservation with Belimumab in Patients with Lupus Nephritis (LN) in Routine Care Settings: Preliminary 24-Month Interim Analysis of the OBSErve-LN Study
- Abstract Number: 1864
Kidney transplant access among patients with end-stage kidney disease secondary to systemic lupus erythematosus
- Abstract Number: 2565
Knee-Related Quality of Life in Secondary Knee Osteoarthritis Among Patients with Inflammatory Arthritis: Influence of Primary Disease Control and Modifiable Factors
- Abstract Number: 0552
Knowledge Gaps in Juvenile Idiopathic Arthritis Recognition Among Non‑Rheumatology Clinicians: Influence of Profession and Clinical Exposure
- Abstract Number: 0535
Knowledge, Attitudes, and Practices Regarding Cervical Cancer Prevention and Screening Among Women With Systemic Lupus Erythematosus: A Multicenter Cross-sectional Survey
- Abstract Number: 2526
Knowledge, Perceptions, and Willingness to Participate in Clinical Trials Among Clinical Trial-Naive SLE Patients: A Pilot Study
ACR Convergence 2026
November 6-11, 2026. Orlando, Florida.